MwanzoREPCF • OTCMKTS
add
RepliCel Life Sciences Inc
Bei iliyotangulia
$ 0.010
Thamani ya kampuni katika soko
elfu 551.83 CAD
Wastani wa hisa zilizouzwa
elfu 2.98
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CVE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 88.43 | 0.00% |
Matumizi ya uendeshaji wa biashara | elfu 168.09 | -59.39% |
Mapato halisi | elfu -216.22 | 73.59% |
Kiwango cha faida halisi | -244.50 | 73.59% |
Mapato kwa kila hisa | — | — |
EBITDA | elfu -79.52 | 75.57% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 10.46 | -67.78% |
Jumla ya mali | elfu 150.97 | -54.45% |
Jumla ya dhima | 5.34M | -23.30% |
Jumla ya hisa | -5.19M | — |
hisa zilizosalia | 65.00M | — |
Uwiano wa bei na thamani | -0.12 | — |
Faida inayotokana na mali | -123.05% | — |
Faida inayotokana mtaji | 5.23% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | elfu -216.22 | 73.59% |
Pesa kutokana na shughuli | elfu -53.11 | 73.48% |
Pesa kutokana na uwekezaji | 0.00 | — |
Pesa kutokana na ufadhili | elfu 44.63 | 4,463,500.00% |
Mabadiliko halisi ya pesa taslimu | elfu -8.48 | 95.77% |
Mtiririko huru wa pesa | elfu -86.26 | 63.60% |
Kuhusu
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
Ilianzishwa
1967
Makao Makuu
Tovuti
Wafanyakazi
1
